Jerome P. Draper is a notable inventor based in Elkins Park, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of growth hormone secretagogues. With a total of 2 patents, Draper's work has implications for both food animals and human health.

Latest Patents

Draper's latest patents include a wet granulation formulation of a growth hormone secretagogue and polymorphic forms of the same compound. The invention focuses on the compound N-1(R)-(1,2-dihydro-1-methanesulfonylspiro-3H-indole-3,4'-piperdin!-1'-yl)carbonyl-2-(phenylmethyloxy)ethyl-2-amino-2-methylpropanamide methanesulfonate. This growth hormone secretagogue is designed to promote growth in food animals, thereby enhancing the efficiency of edible meat production. Additionally, it aims to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion in humans. The polymorphic forms developed by Draper offer advantages in thermodynamic stability and suitability for pharmaceutical formulations.

Career Highlights

Jerome P. Draper is currently associated with Merck & Co., Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of growth hormone secretagogues.

Collaborations

Draper has collaborated with notable colleagues such as David C. Dubost and Michael J. Kaufman, contributing to the collective expertise in his field.

Conclusion

Jerome P. Draper's contributions to the development of growth hormone secretagogues highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to impact both animal husbandry and human health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]